ACNE
Clinical trials for ACNE explained in plain language.
Never miss a new study
Get alerted when new ACNE trials appear
Sign up with your email to follow new studies for ACNE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First mRNA vaccine for acne enters human testing
Disease control Recruiting nowThis early-stage study is testing a new mRNA vaccine designed to help control mild acne. About 120 healthy adults aged 18-45 with mild facial acne will receive two shots of either the vaccine or a placebo. Researchers will track safety, side effects, and whether the vaccine reduc…
Matched conditions: ACNE
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Early testing begins on potential new acne pill
Disease control Recruiting nowThis is the first human study of an experimental oral medication called TVB-3567 for acne. Researchers will test single and multiple doses in 128 healthy adults, some with moderate to severe acne, to check if it's safe and how the body processes it. The study will also see if tak…
Matched conditions: ACNE
Phase: PHASE1 • Sponsor: Sagimet Biosciences Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
First mRNA vaccine for acne enters human testing
Disease control Recruiting nowThis study is testing a new mRNA vaccine designed to help control moderate to severe acne in adults aged 18 to 45. Researchers will give up to three injections at different dose levels to 260 participants to see how safe the vaccine is and if it reduces acne lesions. The goal is …
Matched conditions: ACNE
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New scar treatment tested in Split-Face trial
Symptom relief Recruiting nowThis study is testing whether a product called Tience®, made from human fat tissue, can improve the appearance of acne scars. Twenty participants with moderate to severe scars will receive three injections on one side of their face over three months. Researchers will compare the …
Matched conditions: ACNE
Phase: NA • Sponsor: Linio Biotech Oy • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC